Table 1 Satisfaction and compliance at the end of 3-months trial of Cefaly®
| N (%) | |
|---|---|
| Satisfaction-intent to continuation | |
| Yes | 23 (65,7%) |
| No | 12 (34,3%) |
| Completed 3 months trial | |
| Yes | 27 (81,8%) |
| No | 6 (18,2%) |
| N (%) | |
|---|---|
| Satisfaction-intent to continuation | |
| Yes | 23 (65,7%) |
| No | 12 (34,3%) |
| Completed 3 months trial | |
| Yes | 27 (81,8%) |
| No | 6 (18,2%) |